glp 1 approved for mash CDSCO Clears Wegovy — India's First GLP-1 Approval for Liver Disease, India's drug regulator CDSCO Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on glp-1 liver Current status of
Pay in 4 interest-free payments of $7.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)


















